Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

XSpray Pharma AB (publ)

Closing information (x1000 DKK)

Closing information 2023/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 453 Less Arrow 3 More Arrow 4
Earnings before taxes -120,689 More Arrow -70,312 More Arrow -38,844
EBITDA -122,066 More Arrow -71,225 More Arrow -39,620
Total assets 514,008 Less Arrow 452,932 Less Arrow 448,627
Current assets 146,301 More Arrow 205,098 More Arrow 245,335
Current liabilities 26,802 Less Arrow 21,789 Less Arrow 14,688
Equity capital 465,748 Less Arrow 430,281 More Arrow 431,791
- share capital 20,993 Less Arrow 15,037 Less Arrow 14,003
Employees (average) 26 Less Arrow 22 Less Arrow 20

Financial ratios

Fiscal year 2023/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 90.6% More Arrow 95.0% More Arrow 96.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -23.4% More Arrow -15.5% More Arrow -8.7%
Current ratio 545.9% More Arrow 941.3% More Arrow 1670.3%
Return on equity (ROE) -25.9% More Arrow -16.3% More Arrow -9.0%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 4 Less Arrow 2 More Arrow 3
Chg. No. of employees % 18% Less Arrow 10% More Arrow 18%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.